Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

SODIUM NITRITE

SODIUM NITRITE

Standard Dose
300MG/10ML (30MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SODIUM NITRITE is listed in Drugs@FDA under application 203922 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM NITRITE Form and strength SOLUTION;INTRAVENOUS - 300MG/10ML (30MG/ML) Sponsor HOPE PHARMS Submission history Latest submission status date: 2021-01-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM NITRITE is listed in Drugs@FDA under application 203922 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM NITRITE Form and strength SOLUTION;INTRAVENOUS - 300MG/10ML (30MG/ML) Sponsor HOPE PHARMS Submission history Latest submission status date: 2021-01-13 00:00:00. Submission type: SUPPL.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.